IMP: Board resolution on business performance
Imexpharm Corporation announces the Board resolution dated October 26, 2020 as follows:
HOSE
> CTG: Information on the FS Q3.2020 via the website (29/10/2020)
> E1VFVN30: Announcement after exchange trading 28 Oct 2020 (29/10/2020)
> E1VFVN30: NAV 28 Oct 2020 (29/10/2020)
> FUEVFVND: NAV 28 Oct 2020 (29/10/2020)
> FUEVFVND: Announcement after exchange trading 28 Oct 2020 (29/10/2020)
> FUESSV50: NAV 28 Oct 2020 (29/10/2020)
> FUESSV30: NAV 28 Oct 2020 (29/10/2020)
> FUESSVFL: NAV 28 Oct 2020 (29/10/2020)
> PME: Record date to hold EGM 2020 (29/10/2020)
> D2D: Board resolution on an agreement with a related company (29/10/2020)